Unique ID issued by UMIN | UMIN000036345 |
---|---|
Receipt number | R000041410 |
Scientific Title | Inhibitory effects of amino acids against increasing in serum uric acid levels induced by purine ingestion: a randomized, single-blind, crossover study |
Date of disclosure of the study information | 2019/04/01 |
Last modified on | 2019/08/07 17:30:03 |
Inhibitory effects of amino acids against increasing in serum uric acid levels induced by purine ingestion: a randomized, single-blind, crossover study
Effects of amino acids against increasing in serum uric acid levels induced by purine ingestion
Inhibitory effects of amino acids against increasing in serum uric acid levels induced by purine ingestion: a randomized, single-blind, crossover study
Effects of amino acids against increasing in serum uric acid levels induced by purine ingestion
Japan |
Healthy adults
Adult |
Others
NO
The randomized, single-blind, crossover clinical trial is conducted to confirm the serum uric acid-lowering effects of combined supplementation with amino acids against purine-induced serum uric acid increase in healthy male subjects aged 20 - 64 years with decreased kidney excretion of uric acid.
Safety,Efficacy
Serum uric acid concentration
Excretion amount of urinary uric acid, urinary pH
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Placebo
4
Prevention
Food |
Ingestion of 100 ml water contained 0.2g purine bodies
Ingestion of 100 ml water contained 0.2g purine bodies and essential amino acid
Ingestion of 100 ml water contained 0.2g purine bodies and non-essential amino acid
Ingestion of 100 ml water contained 0.2g purine bodies, essential, and non-essential amino acids
20 | years-old | <= |
65 | years-old | > |
Male
1.20 - 64 years old
2.Healthy male
3.Type of decrease in urinary excretion of uric acid (<0.48 mg/kg/h)
1.Volunteers with a history of diabetes, liver, renal, and heart
2.Volunteers who conducting exercise or diet therapy
3.Volunteers who taking a medicine daily
4.Volunteers with a history of severe diseases ingested medicines
5.Volunteers with a history of drug or food allergy
6.Volunteers with routine use medicines or dietary supplements concerning uric acid-lowering effect
7.Volunteers who participated other clinical trial within three months
8.Volunteers with hepatitis B antigen
9.Volunteers who are judged not to be appropriate as the subjects in this trial
16
1st name | Yasunori |
Middle name | |
Last name | Nakamura |
Asahi Quality and Innovations, Ltd.
Core Technology Laboratories Director
302-0106
1-21,Midori 1-chome,Moriya-shi,Ibaraki
0297-46-1502
yasunori.nakamura@asahigroup-holdings.com
1st name | Shunji |
Middle name | |
Last name | Oshima |
Asahi Quality and Innovations, Ltd.
Core Technology Laboratories Principal Researcher
302-0106
1-21,Midori 1-chome,Moriya-shi,Ibaraki
0297-46-9351
shunji.oshima@asahigroup-holdings.com
Asahi Quality and Innovations, Ltd.
Asahi Quality and Innovations, Ltd.
Self funding
Suda Clinic institutional review board
2-8-14, Takadanobaba, Shinjyuku, Tokyo, Japan
03-6205-6222
suda-clinic_irb@imeq.co.jp
NO
2019 | Year | 04 | Month | 01 | Day |
Unpublished
Completed
2019 | Year | 03 | Month | 18 | Day |
2019 | Year | 03 | Month | 27 | Day |
2019 | Year | 04 | Month | 08 | Day |
2019 | Year | 06 | Month | 30 | Day |
2019 | Year | 03 | Month | 29 | Day |
2019 | Year | 08 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041410
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |